Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Retraction Note to multiple articles in Tumor Biology.

Stigbrand T.

Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. [Epub ahead of print] No abstract available.

PMID:
28792236
2.

The rapidly changing landscape of scientific publishing.

Stigbrand T.

Tumour Biol. 2017 Jan;39(1):1010428316687894. doi: 10.1177/1010428316687894. No abstract available.

PMID:
28121285
3.

Genome wide expression analysis of radiation-induced DNA damage responses in isogenic HCT116 p53+/+ and HCT116 p53-/- colorectal carcinoma cell lines.

Lindgren T, Stigbrand T, Råberg A, Riklund K, Johansson L, Eriksson D.

Int J Radiat Biol. 2015 Jan;91(1):99-111. doi: 10.3109/09553002.2015.959668.

PMID:
25219679
4.

Alterations in gene expression during radiation-induced mitotic catastrophe in HeLa Hep2 cells.

Lindgren T, Stigbrand T, Johansson L, Riklund K, Eriksson D.

Anticancer Res. 2014 Aug;34(8):3875-80.

PMID:
25075008
5.

Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis.

Lindgren T, Stigbrand T, Riklund K, Johansson L, Eriksson D.

Tumour Biol. 2012 Jun;33(3):689-700. doi: 10.1007/s13277-012-0329-z. Epub 2012 Feb 10.

PMID:
22322922
6.

Functional mapping of the anti-idiotypic antibody anti-TS1 scFv using site-directed mutagenesis and kinetic analysis.

Erlandsson A, Holm P, Jafari R, Stigbrand T, Sundström BE.

MAbs. 2010 Nov-Dec;2(6):662-9. doi: 10.4161/mabs.2.6.13275.

7.

Localization of complexed anticytokeratin 8 scFv TS1-218 to HeLa HEp-2 multicellular tumor spheroids and experimental tumors.

Jafari R, Holm P, Sandegren J, Stigbrand T, Sundström BE.

Cancer Biother Radiopharm. 2010 Aug;25(4):455-63. doi: 10.1089/cbr.2010.0785.

PMID:
20707717
8.

TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins.

Paus E, Haugen MH, Olsen KH, Flatmark K, Maelandsmo GM, Nilsson O, Röijer E, Lundin M, Fermér C, Samsonova M, Lebedin Y, Stigbrand T.

Tumour Biol. 2011 Feb;32(1):1-12. doi: 10.1007/s13277-010-0073-1. Epub 2010 Jul 24.

PMID:
20652782
9.

Radiation-induced cell death mechanisms.

Eriksson D, Stigbrand T.

Tumour Biol. 2010 Aug;31(4):363-72. doi: 10.1007/s13277-010-0042-8. Epub 2010 May 20. Review.

PMID:
20490962
10.

Apoptotic signalling in HeLa Hep2 cells following 5 Gy of cobalt-60 gamma radiation.

Eriksson D, Löfroth PO, Johansson L, Riklund K, Stigbrand T.

Anticancer Res. 2009 Nov;29(11):4361-6.

11.

Neurofilament ELISA validation.

Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, Fainardi E, Franciotta D, Freedman MS, Giedraitis V, Gilhus NE, Giovannoni G, Glabinski A, Grieb P, Hartung HP, Hemmer B, Herukka SK, Hintzen R, Ingelsson M, Jackson S, Jacobsen S, Jafari N, Jalosinski M, Jarius S, Kapaki E, Kieseier BC, Koel-Simmelink MJ, Kornhuber J, Kuhle J, Kurzepa J, Lalive PH, Lannfelt L, Lehmensiek V, Lewczuk P, Livrea P, Marnetto F, Martino D, Menge T, Norgren N, Papuć E, Paraskevas GP, Pirttilä T, Rajda C, Rejdak K, Ricny J, Ripova D, Rosengren L, Ruggieri M, Schraen S, Shaw G, Sindic C, Siva A, Stigbrand T, Stonebridge I, Topcular B, Trojano M, Tumani H, Twaalfhoven HA, Vécsei L, Van Pesch V, Vanderstichele H, Vedeler C, Verbeek MM, Villar LM, Weissert R, Wildemann B, Yang C, Yao K, Teunissen CE.

J Immunol Methods. 2010 Jan 31;352(1-2):23-31. doi: 10.1016/j.jim.2009.09.014. Epub 2009 Oct 24.

PMID:
19857497
12.

Iodine-131 induces mitotic catastrophes and activates apoptotic pathways in HeLa Hep2 cells.

Eriksson D, Blomberg J, Lindgren T, Löfroth PO, Johansson L, Riklund K, Stigbrand T.

Cancer Biother Radiopharm. 2008 Oct;23(5):541-9. doi: 10.1089/cbr.2007.0471.

PMID:
18986216
13.

Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation.

Eriksson D, Löfroth PO, Johansson L, Riklund KA, Stigbrand T.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5501s-5508s.

14.

Tumor radioimmunolocalization in nude mice by mono- and divalent- single-chain Fv antiplacental alkaline phosphatase antibodies.

Sheikholvaezin A, Eriksson D, Ahlström KR, Johansson L, Stigbrand T.

Cancer Biother Radiopharm. 2007 Feb;22(1):64-72.

PMID:
17627415
15.

CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.

Pijnenburg YA, Janssen JC, Schoonenboom NS, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P, Teunissen CE.

Dement Geriatr Cogn Disord. 2007;23(4):225-30. Epub 2007 Feb 9.

PMID:
17290105
16.

Proteolytic hydrolysis and purification of the LRP/alfa-2-macroglobulin receptor domain from alpha-macroglobulins.

Barrera DI, Matheus LM, Stigbrand T, Arbeláez LF.

Protein Expr Purif. 2007 May;53(1):112-8. Epub 2006 Dec 16.

PMID:
17257854
17.

Construction and purification of a covalently linked divalent tandem single-chain Fv antibody against placental alkaline phosphatase.

Sheikholvaezin A, Eriksson D, Riklund K, Stigbrand T.

Hybridoma (Larchmt). 2006 Oct;25(5):255-63.

PMID:
17044780
18.

Optimizing the generation of recombinant single-chain antibodies against placental alkaline phosphatase.

Sheikholvaezin A, Sandström P, Eriksson D, Norgren N, Riklund K, Stigbrand T.

Hybridoma (Larchmt). 2006 Aug;25(4):181-92.

PMID:
16934014
19.

Structural studies of human alkaline phosphatase in complex with strontium: implication for its secondary effect in bones.

Llinas P, Masella M, Stigbrand T, Ménez A, Stura EA, Le Du MH.

Protein Sci. 2006 Jul;15(7):1691-700.

20.

Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury.

Bazarian JJ, Zemlan FP, Mookerjee S, Stigbrand T.

Brain Inj. 2006 Jun;20(7):759-65.

PMID:
16809208
21.

[The Medical Biobank--a unique resource for medical research].

Stigbrand T, Rymo L, Lernmark A.

Lakartidningen. 2005 Sep 26-Oct 2;102(39):2769-72. Swedish. No abstract available.

PMID:
16245551
22.

Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis.

Norgren N, Edelstam A, Stigbrand T.

Brain Res Bull. 2005 Oct 30;67(4):264-8.

PMID:
16182933
23.

In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives.

Erlandsson A, Eriksson D, Johansson L, Riklund K, Stigbrand T, Sundström BE.

Mol Immunol. 2006 Feb;43(6):599-606. Epub 2005 Jun 22.

PMID:
15978666
24.

Structural studies of human placental alkaline phosphatase in complex with functional ligands.

Llinas P, Stura EA, Ménez A, Kiss Z, Stigbrand T, Millán JL, Le Du MH.

J Mol Biol. 2005 Jul 15;350(3):441-51.

PMID:
15946677
25.

Interfering with cancer: a brief outline of advances in RNA interference in oncology.

Rye PD, Stigbrand T.

Tumour Biol. 2004 Sep-Dec;25(5-6):329-36. Review.

PMID:
15627900
26.

The bioinformatic catalyst in the kallikrein family.

Rye PD, Stigbrand T.

Tumour Biol. 2004 Sep-Dec;25(5-6):327-8. No abstract available.

PMID:
15627899
27.

Up close and personal: molecular diagnostics in oncology.

Rye PD, Rittenhouse H, Stigbrand T.

Tumour Biol. 2004 Jul-Aug;25(4):217-20.

PMID:
15557760
28.

Neurofilament and glial fibrillary acidic protein in multiple sclerosis.

Norgren N, Sundström P, Svenningsson A, Rosengren L, Stigbrand T, Gunnarsson M.

Neurology. 2004 Nov 9;63(9):1586-90.

PMID:
15534240
29.

Tumor marker workshops.

Rye PD, Nustad K, Stigbrand T.

Tumour Biol. 2003 Aug-Sep;24(4):165-71.

PMID:
14654709
30.

Elevated neurofilament levels in neurological diseases.

Norgren N, Rosengren L, Stigbrand T.

Brain Res. 2003 Oct 10;987(1):25-31.

PMID:
14499942
31.

Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.

Erlandsson A, Holm P, Ullén A, Stigbrand T, Sundström BE.

J Mol Recognit. 2003 May-Jun;16(3):157-63.

PMID:
12833571
32.

Native and transformed alpha2-macroglobulin in plasma from patients with multiple sclerosis.

Gunnarsson M, Sundström P, Stigbrand T, Jensen PE.

Acta Neurol Scand. 2003 Jul;108(1):16-21.

PMID:
12807388
33.

Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.

Eriksson D, Joniani HM, Sheikholvaezin A, Löfroth PO, Johansson L, Riklund Ahlström K, Stigbrand T.

Eur J Nucl Med Mol Imaging. 2003 Jun;30(6):895-906. Epub 2003 Apr 30.

PMID:
12721768
34.

Tumour therapy with radionuclides: assessment of progress and problems.

Carlsson J, Forssell Aronsson E, Hietala SO, Stigbrand T, Tennvall J.

Radiother Oncol. 2003 Feb;66(2):107-17. Review.

PMID:
12648782
35.

Stimulation of peripheral blood mononuclear cells with lipopolysaccharide induces expression of the plasma protein alpha2-macroglobulin.

Gunnarsson M, Frängsmyr L, Stigbrand T, Jensen PE.

Protein Expr Purif. 2003 Feb;27(2):238-43.

PMID:
12597882
36.

Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop.

Magnusson P, Arlestig L, Paus E, Di Mauro S, Testa MP, Stigbrand T, Farley JR, Nustad K, Millán JL.

Tumour Biol. 2002 Jul-Aug;23(4):228-48.

PMID:
12499779
37.

Apoptosis in HeLa Hep2 cells is induced by low-dose, low-dose-rate radiation.

Mirzaie-Joniani H, Eriksson D, Johansson A, Löfroth PO, Johansson L, Ahlström KR, Stigbrand T.

Radiat Res. 2002 Nov;158(5):634-40.

PMID:
12385641
38.

A new antibody recognizing the vIII mutation of human epidermal growth factor receptor.

Ohman L, Gedda L, Hesselager G, Larsson R, Nister M, Stigbrand T, Wester K, Carlsson J.

Tumour Biol. 2002 Mar-Apr;23(2):61-9.

PMID:
12065843
39.

Monoclonal antibodies selective for low molecular weight neurofilaments.

Norgren N, Karlsson JE, Rosengren L, Stigbrand T.

Hybrid Hybridomics. 2002 Feb;21(1):53-9.

PMID:
11991817
40.

The combination of external beam radiotherapy and experimental radioimmunotargeting with a monoclonal anticytokeratin antibody.

Johansson A, Eriksson D, Ullén A, Löfroth PO, Johansson L, Riklund-Ahlström K, Stigbrand T.

Cancer. 2002 Feb 15;94(4 Suppl):1314-9.

41.

Idiotypic-anti-idiotypic complexes and their in vivo metabolism.

Johansson A, Erlandsson A, Eriksson D, Ullén A, Holm P, Sundström BE, Roux KH, Stigbrand T.

Cancer. 2002 Feb 15;94(4 Suppl):1306-13.

42.

Apoptosis induced by low-dose and low-dose-rate radiation.

Mirzaie-Joniani H, Eriksson D, Sheikholvaezin A, Johansson A, Löfroth PO, Johansson L, Stigbrand T.

Cancer. 2002 Feb 15;94(4 Suppl):1210-4.

43.

Accumulation of(125)iodine labeled interleukin-2 in the pancreas of NOD mice.

Rolandsson O, Stigbrand T, Riklundåhlström K, Eary J, Greenbaum C.

J Autoimmun. 2001 Dec;17(4):281-7.

PMID:
11771952
44.
45.

Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): a dosimetric evaluation.

Rydh A, Riklund Ahlström K, Widmark A, Johansson L, Nilsson S, Bergh A, Damber JE, Stigbrand T, Hietala SO.

Urol Res. 2001 Jun;29(3):216-20.

PMID:
11482450
46.

Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization.

Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Ménez A, Le Du MH.

J Biol Chem. 2001 Aug 17;276(33):31171-8. Epub 2001 Jun 6.

47.

Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity.

Le Du MH, Stigbrand T, Taussig MJ, Menez A, Stura EA.

J Biol Chem. 2001 Mar 23;276(12):9158-65. Epub 2000 Dec 20.

48.

Immunochemical aberrations of alpha2-macroglobulin purified from a patient with multiple sclerosis.

Gunnarsson M, Stigbrand T, Jensen PE.

Acta Neurol Scand. 2000 Dec;102(6):406-9.

PMID:
11125759
49.

Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 workshop.

Nap M, van Wel T, Andrés C, Bellanger L, Bodenmüller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Meier T, Seguin P, Sjödin A, Stigbrand T, Sundström BE, van Dalen A, Wiebelhaus E, Wiklund B, Hilgers J.

Tumour Biol. 2001 Jan-Feb;22(1):4-10.

PMID:
11054021
50.

The versatility of cytokeratins as tumor markers.

Stigbrand T.

Tumour Biol. 2001 Jan-Feb;22(1):1-3.

PMID:
11054020

Supplemental Content

Loading ...
Support Center